TABLE 1.
Patients with therapy modifications due to abnormal laboratory values
| Patient | OPAT antibiotic | Change | Reason | Timinga |
|---|---|---|---|---|
| 1 | Cefazolin | Changed to ceftriaxone | Increased creatinine | 12 |
| 2 | Cefazolin | Changed to ceftriaxone | Increased creatinine | 5 |
| 3 | Cefazolin | Changed to levofloxacin | Increased creatinine | 18 |
| 4 | Cefazolin | Changed to levofloxacin | Neutropenia | 22 |
| 5 | Cefazolin | Changed to levofloxacin | Thrombocytopenia | 33 |
| 6 | Cefazolin | Changed to vancomycin | Hepatotoxicity | 21 |
| 7 | Cefazolin | Changed to levofloxacin | Cytopenia | 20 |
| 8 | Cefepime | Dose reduced | Increased creatinine | 22 |
| 9 | Cefepime | Changed to levofloxacin | Cytopenia | 12 |
| 10 | Cefepime | Changed to levofloxacin | Leukopenia | 25 |
| 11 | Cefepime | Dose reduced | Increased creatinine | 22 |
| 12 | Ceftriaxone | Changed to ampicillin-sulbactam | Hepatotoxicity | 26 |
| 13 | Penicillin | Changed to ceftriaxone | Increased creatinine | 12 |
| 14 | Piperacillin-tazobactam | Changed to ertapenem | Increased creatinine | 19 |
| 15 | Nafcillin | Antibiotics stopped | Eosinophilia | 28 |
Day of OPAT that the change occurred.